Titlebook: Cardiac Pacing for the Clinician; Fred M. Kusumoto,Nora F. Goldschlager Book 2008Latest edition Springer-Verlag US 2008 Defibrillator.Impl

馬用

書目名稱Cardiac Pacing for the Clinician影響因子(影響力)




書目名稱Cardiac Pacing for the Clinician影響因子(影響力)學科排名




書目名稱Cardiac Pacing for the Clinician網(wǎng)絡公開度




書目名稱Cardiac Pacing for the Clinician網(wǎng)絡公開度學科排名




書目名稱Cardiac Pacing for the Clinician被引頻次




書目名稱Cardiac Pacing for the Clinician被引頻次學科排名




書目名稱Cardiac Pacing for the Clinician年度引用




書目名稱Cardiac Pacing for the Clinician年度引用學科排名




書目名稱Cardiac Pacing for the Clinician讀者反饋




書目名稱Cardiac Pacing for the Clinician讀者反饋學科排名

多節(jié)

神經(jīng)

無聊點好

pplementary material: .Since the publication of the first edition of Cardiac Pacing for the Clinician, the use of implantable cardiac devices has expanded rapidly. Certain classes of devices such as implantable loop recorders and cardiac resynchronization pacing systems were not commonly used when t

圍巾

https://doi.org/10.1007/978-3-322-86144-3al risk of significant morbidity and even mortality. The management of device complications has become a subspecialty of cardiology and cardiovascular surgery (1–5). It requires special training to acquire the skills for successful results.

脫水

https://doi.org/10.1007/978-3-322-86144-3svenous pacing and transesophageal pacing was demonstrated. Temporary pacing has become the standard method for providing immediate treatment of severe bradycardias and certain tachycardias for the past 20 years.

脫水

Obscure

https://doi.org/10.1007/978-3-322-86214-3is group of patients, the optimal pacing mode, pacing system and site of ventricular stimulation for sinus node dysfunction remains controversial. The available data for the diagnosis and treatment of sinus node dysfunction are reviewed in this chapter.

INCH

斷言

https://doi.org/10.1007/978-3-322-86415-4antable cardioverter-defibrillator (ICD). Complications related to the implanted device can also lead to a need for management within the critical care setting. Finally, a permanent cardiac device can interact, and at times interfere, with therapies such as intravenous monitoring line placement, and external cardioversion and defibrillation.